Small Molecules

Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right?

The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D

Organizations all over the globe are taking action against drug resistance.

The rise of drug resistance has left us facing a future with few effective antibiotics. Do the next-generation antibiotics in the pipeline offer hope?

Manufacturing stem cells for use in research is one thing; doing it on a commercial scale is an entirely different ballgame.

Antibiotics were once hailed as wonder drugs in the war against infection, but now it looks like bacteria might have the upper hand. How can we turn the tide?

An FDA Warning Letter can be a real wake up call. How can you address the root of the problem?

Maximizing operational excellence – what have we learned and where do we go next?

Today’s pharmaceutical manufacturing operations capture huge amounts of data. Unfortunately, in many cases the data pass by without actual context.

We now know more than ever before about the complex ecosystem of bacteria, fungi, and viruses within our bodies